Earnings
CCXI
46.54
-1.29%
-0.61
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
32.30M
404.27M
--
169.00K
--
--
0.00
--
--
--
4.83M
--
441.57M
52.07M
--
23.80M
--
--
--
--
1.46M
77.33M
518.90M
--
12.88M
0.00
--
--
--
--
--
19.79M
--
--
--
12.59M
51.56M
18.10M
--
--
--
63.63M
81.73M
133.29M
69.00K
870.79M
-485.34M
--
--
--
385.61M
385.61M
518.90M
FY 2019-12-31
39.18M
133.61M
--
176.00K
--
--
0.00
--
--
--
1.40M
--
174.36M
3.86M
--
29.45M
--
--
--
--
1.41M
34.72M
209.08M
--
1.53M
0.00
--
--
--
--
--
18.71M
--
--
--
38.84M
59.08M
19.79M
--
--
--
64.22M
84.00M
143.08M
60.00K
495.62M
-429.99M
--
--
--
66.00M
66.00M
209.08M
FY 2018-12-31
28.09M
148.90M
--
2.06M
--
--
0.00
--
--
--
2.34M
--
181.38M
1.54M
--
0.00
--
--
--
--
390.00K
1.93M
183.31M
--
966.00K
0.00
--
--
--
--
--
12.16M
--
--
--
51.27M
64.40M
19.69M
--
--
--
84.49M
104.18M
168.57M
51.00K
389.40M
-374.50M
--
--
--
14.74M
14.74M
183.31M
FY 2017-12-31
40.02M
87.27M
--
51.09M
--
--
0.00
--
--
--
1.45M
--
179.83M
1.21M
--
7.93M
--
--
--
--
359.00K
9.50M
189.33M
--
1.40M
0.00
--
--
--
--
--
7.56M
--
--
--
23.97M
32.94M
4.68M
--
--
--
72.45M
77.12M
110.06M
49.00K
368.55M
-289.20M
--
--
--
79.27M
79.27M
189.33M
FY 2016-12-31
12.02M
105.74M
--
30.20M
--
--
0.00
--
--
--
722.00K
--
148.69M
905.00K
--
6.00M
--
--
--
--
279.00K
7.18M
155.87M
--
671.00K
0.00
--
--
--
--
--
8.22M
--
--
--
29.44M
38.34M
0.00
--
--
--
67.65M
67.65M
105.98M
48.00K
356.97M
-307.06M
--
--
--
49.89M
49.89M
155.87M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out CCXI latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze ChemoCentryx recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.